Living Donor Liver Transplantation from a Hepatitis C Treated Donor
Author Information
Author(s): Hidaka Masaaki, Takatsuki Mitsuhisa, Soyama Akihiko, Miyaaki Hisamitsu, Ichikawa Tatsuki, Nakao Kazuhiko, Kanematsu Takashi, Eguchi Susumu
Primary Institution: Nagasaki University Graduate School of Biomedical Sciences
Hypothesis
Can a donor with a sustained viral response after hepatitis C treatment safely donate their liver?
Conclusion
A donor with a sustained viral response after interferon therapy can be considered for living donor liver transplantation if no other options are available.
Supporting Evidence
- The donor had a sustained viral response after hepatitis C treatment.
- Both the donor and recipient had good liver function after transplantation.
- The donor's liver function recovered immediately after donation.
Takeaway
A woman who was treated for hepatitis C was able to donate her liver to her brother, and both are doing well after the surgery.
Methodology
Case report detailing the evaluation and outcomes of a living donor liver transplantation.
Potential Biases
Potential bias in donor selection and follow-up assessments.
Limitations
The study is based on a single case, limiting generalizability.
Participant Demographics
A 46-year-old Japanese woman donor and her 36-year-old brother recipient.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website